Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bleeding Profile and Insertion Easiness of Second Consecutive Mirena
NCT00393198Phase 4Completed
- Sponsor
- Bayer
- Start
- Oct 2006
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 4, randomised, double-blind trial of levonorgestrel intrauterine system in contraception and Menorrhagia (3 arms), sponsored by Bayer. Primary endpoint: Bleeding profile at 5 years. Started Oct 2006; status: completed.
02
Drugs
levonorgestrel intrauterine system
03
Conditions
contraceptionMenorrhagia
Beyond the preview
Go deeper on NCT00393198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00393198.